LEADER 01132nam 2200409 450 001 9910155448403321 005 20230808205546.0 010 $a3-86802-355-0 010 $a3-86802-693-2 035 $a(CKB)4340000000019000 035 $a(MiAaPQ)EBC4753320 035 $a(EXLCZ)994340000000019000 100 $a20161214h20162016 uy 0 101 0 $ager 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 14$aDas ESP8266-Projektbuch $eHeimautomation mit dem WLAN-Chip /$fMartin Mohr 210 1$aFrankfurt am Main, [Germany] :$centwickler.press,$d2016. 210 4$dİ2016 215 $a1 online resource (152 pages) $cillustrations, tables 300 $aIncludes index. 311 $a3-86802-168-X 606 $aAutomation 606 $aSystem design 615 0$aAutomation. 615 0$aSystem design. 676 $a670.427 700 $aMohr$b Martin$01374512 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910155448403321 996 $aDas ESP8266-Projektbuch$93407756 997 $aUNINA LEADER 04015nam 22004573 450 001 9910985658003321 005 20250321194320.0 010 $a9789815196474 035 $a(CKB)30556818700041 035 $a(MiAaPQ)EBC31187476 035 $a(Au-PeEL)EBL31187476 035 $a(Exl-AI)31187476 035 $a(OCoLC)1424748882 035 $a(EXLCZ)9930556818700041 100 $a20240302d2024 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMarine Biopharmaceuticals 205 $a1st ed. 210 1$aSharjah :$cBentham Science Publishers,$d2024. 210 4$dİ2024. 215 $a1 online resource (373 pages) 311 08$a9789815196481 327 $aCover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- Introduction -- Marine Bioprospecting -- Promising Pharmaceutical Compounds of Marine Plants: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Sponges: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Cnidarians: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Bryozoans: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Worms: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Shellfish: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Tunicates: Their Chemistry and Therapeutic Applications -- Promising Pharmaceutical Compounds of Marine Fishes: Their Chemistry and Therapeutic Applications -- Marine Biopharmaceutical Compounds against SARS-CoV-2 -- Marine Biopharmaceuticals in Pipeline -- New PG Degree Course, Marine Bio-Pharmacy: Scope and Career Prospects -- References -- Subject Index -- Back Cover$7Generated by AI. 330 $aMarine Biopharmaceuticals: Scope and Prospects is a collaboration of experts in pharmacology, biology and biochemistry with a focus on Marine Bioprospecting. The book provides an in-depth exploration of promising pharmaceutical compounds found in various marine biota and their therapeutic applications. The comprehensive contents cover marine ecosystems, marine biopharmaceutical, and delve into the chemistry and therapeutic applications of compounds from diverse marine organisms such as seaweeds, sponges, cnidarians, bryozoans, worms, shellfish, tunicates, and fishes. The chapters also highlight approved and marketed marine biota-derived drugs and marine biota-derived drug candidates currently under clinical trials. Marine biopharmaceutical compounds targeting SARS-CoV-2 are also covered, reflecting the latest developments in the field. The editors conclude the book by advocating for the establishment of professional grade Marine Biopharmacy courses at university level to contribute to this emerging field. This reference serves as a guide for researchers and instructors in disciplines such as Pharmaceutical Sciences, Marine Biology, Marine Microbiology, Marine Biochemistry, and Marine Biotechnology. Moreover, it is positioned as a standard reference for libraries in colleges and universities, offering critical insights for drug companies engaged in the development of new drugs from marine biopharmaceuticals. Readership Academics, instructors and professionals in the field of pharmacology and marine science. 606 $aMarine pharmacology$7Generated by AI 606 $aMarine biotechnology$7Generated by AI 615 0$aMarine pharmacology 615 0$aMarine biotechnology 700 $aRamesh$b Santhanam$01791175 701 $aSanthanam$b Ramasamy$01059931 701 $aSankar$b Veintramuthu$01791176 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910985658003321 996 $aMarine Biopharmaceuticals$94328087 997 $aUNINA LEADER 04702nam 22008295 450 001 9911015855803321 005 20250731122937.0 010 $a3-031-93347-8 024 7 $a10.1007/978-3-031-93347-9 035 $a(MiAaPQ)EBC32189519 035 $a(Au-PeEL)EBL32189519 035 $a(CKB)39567922600041 035 $a(DE-He213)978-3-031-93347-9 035 $a(EXLCZ)9939567922600041 100 $a20250702d2025 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHealthcare Delivery for Children with Medical Complexity $eThe State of the Art and Future Directions /$fby Nancy Murphy, Justin C. Alvey, Jennifer Brinton, Natalie Heyrend Darro, Jason Fox, E. Avery Hill, Kathleen Irby, Andrew Robertson, Laura Smals-Murphy 205 $a1st ed. 2025. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2025. 215 $a1 online resource (158 pages) 225 1 $aSpringerBriefs in Child Health,$x2625-2880 311 08$a3-031-93346-X 327 $a1. Children with Medical Complexity: Who They Are and Why Caring for Them Matters -- 2. The Specialty and Scope of Complex Care Pediatrics -- 3. Community and Family Partnerships -- 4. Ethical Considerations in the Care of Children with Medical Complexity -- 5. Implications for Policy and Practice -- 6. Looking Ahead: Children with Medical Complexity and Public Health, Workforce Training, and Advocacy. 330 $aThis book describes the state of the art of pediatric complex care, sharing the authors' decades of experience in an academic health center to illustrate points. The authors are pediatric generalist and subspecialist providers, among others, who care for children with medical complexity in a Pediatric Complex Care program. Children with medical complexity (CMC) are a small yet impactful pediatric population, a subset of children with special healthcare needs that include multi-system, non-categorical, chronic conditions, high resource and technology dependencies, medical fragility, and functional impairments. CMC do not fit into traditional systems of care. They require the continuous collaboration of pediatric subspecialists, community and public health partners, and family caregivers. The field of Pediatric Complex Care is rapidly evolving, yet lacks a well-prepared workforce built on clear educational competencies and clinical guidelines. In this compact volume, the authors review models of care for CMC, and how these models intersect with larger public health systems, dependent on collaborative networks of community-based and family partnerships. They explore ethical considerations, including implications for policy and practice. Among the topics covered are: The Specialty and Scope of Complex Care Pediatrics Ethical Considerations in the Care of Children with Medical Complexity Implications for Policy and Practice Healthcare Delivery for Children with Medical Complexity: The State of the Art and Future Directions is an essential resource for all medical professionals who care for CMC, public policy makers, medical educators, healthcare leaders, and community partners and stakeholders. 410 0$aSpringerBriefs in Child Health,$x2625-2880 606 $aPublic health 606 $aPediatrics 606 $aMedical policy 606 $aMedical care 606 $aMedical education 606 $aMedical ethics 606 $aPublic Health 606 $aPediatrics 606 $aHealth Policy 606 $aHealth Care 606 $aMedical Education 606 $aMedical Ethics 615 0$aPublic health. 615 0$aPediatrics. 615 0$aMedical policy. 615 0$aMedical care. 615 0$aMedical education. 615 0$aMedical ethics. 615 14$aPublic Health. 615 24$aPediatrics. 615 24$aHealth Policy. 615 24$aHealth Care. 615 24$aMedical Education. 615 24$aMedical Ethics. 676 $a613 676 $a614 700 $aMurphy$b Nancy$01834044 701 $aAlvey$b Justin C$01834045 701 $aBrinton$b Jennifer$01834046 701 $aDarro$b Natalie Heyrend$01834047 701 $aFox$b Jason$01680303 701 $aHill$b E. Avery$01834048 701 $aIrby$b Kathleen$01834049 701 $aRobertson$b Andrew$0173963 701 $aSmals-Murphy$b Laura$01834050 701 $aAmes$b Stefanie$01834051 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911015855803321 996 $aHealthcare Delivery for Children with Medical Complexity$94409154 997 $aUNINA